Muscle Inflammation Completed Phase 2 Trials for Rituximab (DB00073)

Also known as: Inflammation; Muscle / Myositis / Myositis unspecified (disorder) / Inflammatory disorder of muscle (disorder) / Inflammatory myopathy NOS / Myositis (disorder) / Myalgia &/or myositis: [NOS] / Myositis, unspecified

IndicationStatusPhase
DBCOND0042362 (Muscle Inflammation)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00106184Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)Treatment
NCT00774462Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia GravisTreatment